JP2024544060A5 - - Google Patents
Info
- Publication number
- JP2024544060A5 JP2024544060A5 JP2024532219A JP2024532219A JP2024544060A5 JP 2024544060 A5 JP2024544060 A5 JP 2024544060A5 JP 2024532219 A JP2024532219 A JP 2024532219A JP 2024532219 A JP2024532219 A JP 2024532219A JP 2024544060 A5 JP2024544060 A5 JP 2024544060A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- groups
- independently selected
- optionally substituted
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284195P | 2021-11-30 | 2021-11-30 | |
| US63/284,195 | 2021-11-30 | ||
| PCT/US2022/051274 WO2023101981A1 (en) | 2021-11-30 | 2022-11-29 | Spirocyclic inhibitors of apol1 and methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544060A JP2024544060A (ja) | 2024-11-27 |
| JP2024544060A5 true JP2024544060A5 (cg-RX-API-DMAC7.html) | 2025-10-30 |
Family
ID=84946826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532219A Pending JP2024544060A (ja) | 2021-11-30 | 2022-11-29 | Apol1のスピロ環式阻害剤およびこれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250084094A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4440697A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544060A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118632850A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022401847A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3240523A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023101981A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3897833T (lt) | 2018-12-17 | 2026-04-27 | Vertex Pharmaceuticals Incorporated | Apol1 inhibitoriai ir jų panaudojimo būdai |
| EP4097083A1 (en) | 2020-01-29 | 2022-12-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| EP4146633A4 (en) | 2020-05-07 | 2024-09-25 | Rambam Med-Tech Ltd. | COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1 |
| JP2023530271A (ja) | 2020-06-12 | 2023-07-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤及びこれを使用する方法 |
| CN115867543A (zh) | 2020-06-12 | 2023-03-28 | 弗特克斯药品有限公司 | Apol1抑制剂的固体形式及其使用方法 |
| BR112023003423A2 (pt) | 2020-08-26 | 2023-03-21 | Vertex Pharma | Inibidores de apol1 e métodos de uso destes |
| US12612379B2 (en) | 2021-11-30 | 2026-04-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
| MX2024008868A (es) | 2022-01-18 | 2024-09-23 | Maze Therapeutics Inc | Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3897833T (lt) * | 2018-12-17 | 2026-04-27 | Vertex Pharmaceuticals Incorporated | Apol1 inhibitoriai ir jų panaudojimo būdai |
| EP4097083A1 (en) * | 2020-01-29 | 2022-12-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| EP4146633A4 (en) * | 2020-05-07 | 2024-09-25 | Rambam Med-Tech Ltd. | COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1 |
-
2022
- 2022-11-29 AU AU2022401847A patent/AU2022401847A1/en active Pending
- 2022-11-29 EP EP22843526.9A patent/EP4440697A1/en active Pending
- 2022-11-29 CN CN202280089820.5A patent/CN118632850A/zh active Pending
- 2022-11-29 CA CA3240523A patent/CA3240523A1/en active Pending
- 2022-11-29 JP JP2024532219A patent/JP2024544060A/ja active Pending
- 2022-11-29 WO PCT/US2022/051274 patent/WO2023101981A1/en not_active Ceased
- 2022-11-29 US US18/714,031 patent/US20250084094A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023539194A5 (cg-RX-API-DMAC7.html) | ||
| JP2025505200A5 (cg-RX-API-DMAC7.html) | ||
| JP2024543934A5 (cg-RX-API-DMAC7.html) | ||
| JP2025505644A5 (cg-RX-API-DMAC7.html) | ||
| RU2405774C2 (ru) | Гетероциклические ингибиторы аспартилпротеазы | |
| IL300298B2 (en) | Inhibitors of apol1 and methods of using same | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| RU2328486C2 (ru) | Производные 2-пиридона в качестве ингибиторов нейтрофильной эластазы | |
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2025505647A5 (cg-RX-API-DMAC7.html) | ||
| RU2003110577A (ru) | Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами | |
| JP2024001048A5 (cg-RX-API-DMAC7.html) | ||
| JP2007511527A5 (cg-RX-API-DMAC7.html) | ||
| HUP0000449A2 (hu) | N-szubsztituált dioxo-tiazolidil-benzamid-származékok és eljárás a vegyületek előállítására | |
| RU2003104821A (ru) | Новые производные фенилаланина | |
| JP2019512485A5 (cg-RX-API-DMAC7.html) | ||
| RU92004336A (ru) | Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты | |
| JP2025505645A5 (cg-RX-API-DMAC7.html) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| KR930016395A (ko) | 2-시아노-3-히드록시엔아미드, 그의 제조 방법, 그를 함유한 제약 조성물 및 의약으로서의 그의 용도 | |
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| JP2022533939A5 (cg-RX-API-DMAC7.html) | ||
| JPH0725864A (ja) | 化学療法剤としての1,2,4−ジチアゾリウム塩類の使用 | |
| RU2007116987A (ru) | Новые соединения | |
| RU2004130487A (ru) | Производные азетидина в качестве антагонистов ccr-3 рецептора |